Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact and complete genome characterisation of viruses involved in outbreaks of gastroenteritis in a farrow-to-finish holding. | Sci Rep | 2023 | 37907693 | PubTator, text mining | PubMed |
| Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis. | J Virol | 2023 | 37905840 | PubTator, text mining | PubMed |
| Isolation, identification, and pathogenicity of porcine epidemic diarrhea virus. | Front Microbiol | 2023 | 37904874 | PubTator, text mining | PubMed |
| In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1. | Vaccines (Basel) | 2023 | 37896937 | PubTator, text mining | PubMed |
| Molecular Epidemiology of Rotavirus A in Calves: Evolutionary Analysis of a Bovine G8P[11] Strain and Spatio-Temporal Dynamics of G6 Lineages in the Americas. | Viruses | 2023 | 37896894 | PubTator, text mining | PubMed |
| Special Issue: "Innate Immunity to Virus Infection, 1st Edition". | Viruses | 2023 | 37896837 | PubTator, text mining | PubMed |
| A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization Assay. | Viruses | 2023 | 37896813 | PubTator, text mining | PubMed |
| Reverse Genetics Systems for Emerging and Re-Emerging Swine Coronaviruses and Applications. | Viruses | 2023 | 37896780 | PubTator, text mining | PubMed |
| Molecular Characterization of Complete Genome Sequence of an Avian Coronavirus Identified in a Backyard Chicken from Tanzania. | Genes (Basel) | 2023 | 37895200 | PubTator, text mining | PubMed |
| Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses. | Biomolecules | 2023 | 37892134 | PubTator, text mining | PubMed |
| Genomic analysis of two rare human G3P[9] rotavirus strains in Ningxia, China. | Infect Genet Evol | 2023 | 37890809 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase ZBTB25 suppresses beta coronavirus infection through ubiquitination of the main viral protease MPro. | J Biol Chem | 2023 | 37890782 | PubTator, text mining | PubMed |
| Prevalence and Genomic Characterization of Rotavirus A from Domestic Pigs in Zambia: Evidence for Possible Porcine-Human Interspecies Transmission. | Pathogens | 2023 | 37887715 | PubTator, text mining | PubMed |
| SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1. | Front Immunol | 2023 | 37854611 | PubTator, text mining | PubMed |
| Reversible and irreversible inhibitors of coronavirus Nsp15 endoribonuclease. | J Biol Chem | 2023 | 37832873 | PubTator, text mining | PubMed |
| Recombinant rotavirus expressing the glycosylated S1 protein of SARS-CoV-2. | J Gen Virol | 2023 | 37830788 | PubTator, text mining | PubMed |
| LINC01343 targets miR-526b-5p to facilitate the development of hepatocellular carcinoma by upregulating ROBO1. | Sci Rep | 2023 | 37828032 | PubTator, text mining | PubMed |
| The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity. | BMB Rep | 2023 | 37817441 | PubTator, text mining | PubMed |
| Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CLPro) activity in silico and in vitro. | Sci Rep | 2023 | 37816832 | PubTator, text mining | PubMed |
| High Mortality With COVID-19 Acute Pericarditis. | J Am Heart Assoc | 2023 | 37815041 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=13